🇺🇸 FDA
Patent

US 7868013

Cycloalkyl substituted pyrimidinediamine compounds and their uses

granted A61KA61K31/505A61K31/506

Quick answer

US patent 7868013 (Cycloalkyl substituted pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/505, A61K31/506, A61P, A61P1/04